Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
, Dilip Davda, , and have given "Apply" recommendation to Eris Lifesciences IPO. recommend to "Avoid" the IPO.
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 5 | 0 | 0 | 1 | 0 |
| % | 83.33 | 0.00 | 0.00 | 16.67 | 0.00 |
| Reviewer | Recommendation | Past Reviews |
|---|---|---|
| Apply |  |
|
| Avoid | |
|
| Dilip Davda | Apply | |
| Apply | |
|
| Apply | |
|
| Apply | |
The Captial Market (CapitalMarket.com) rating for Eris Lifesciences IPO is 45. Their analysis recommends May subscribe for the IPO.
| Reviewer | Rating Score | Rating |
|---|---|---|
| Capital Market | 45 | May subscribe |
[Dilip Davda] Investors may consider investment for medium to long term in this niche player having better penetration. Read detail review...
Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
